Symptomatic Hyperlactatemia Associated with Nucleoside Analogue Reverse-Transcriptase Inhibitor Use in HIV-Infected Patients: A Report of 24 Cases in a Resource-Limited Setting (Uganda)-Reference-Cited by-同舟云学术

Symptomatic Hyperlactatemia Associated with Nucleoside Analogue Reverse-Transcriptase Inhibitor Use in HIV-Infected Patients: A Report of 24 Cases in a Resource-Limited Setting (Uganda)

Published:2007-08-15 Issue:4 Volume:45 Page:514-517
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

Songa P. M.,Castelnuovo B.,Mugasha E. B.,Ocama P.,Kambugu A.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/45/4/514/1181712/45-4-514.pdf

Reference12 articles.

1. Hyperlactatemia and Antiretroviral Therapy: The Swiss HIV Cohort Study

2. Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors

3. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome

4. Adverse effects of reverse transcriptase inhibitors

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal patients’ cohorts for impactful research and HIV care at the Infectious Diseases Institute;African Health Sciences;2022-08-26

2. Lactic acidosis in patients with hepatitis C virus cirrhosis and combined ribavirin/sofosbuvir treatment;Journal of Hepatology;2016-04

3. The role of lactate besides the lactic acidosis;CLIN TER;2013

4. Fatal Toxicity from Symptomatic Hyperlactataemia;Drug Safety;2011-06

5. Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosis;Antiviral Therapy;2011